|
Volumn 77, Issue 3, 2001, Pages 208-212
|
Lung cancer in patients younger than 40 years of age
a a a a a a a a |
Author keywords
Combined modality therapy; Lung cancer; Prognosis; Surgical therapy; Young patients
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL FEATURE;
CONTROLLED STUDY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
LUNG ADENOCARCINOMA;
LUNG CANCER;
MAJOR CLINICAL STUDY;
MALE;
MULTIMODALITY CANCER THERAPY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROGNOSIS;
SQUAMOUS CELL CARCINOMA;
ADULT;
AGE OF ONSET;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
NEOPLASM STAGING;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
|
EID: 0034948043
PISSN: 00224790
EISSN: None
Source Type: Journal
DOI: 10.1002/jso.1096 Document Type: Article |
Times cited : (44)
|
References (18)
|